COST Q1 2026 Earnings EPS Falls Short of Estimates on Margin Pressure Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges ERO Q1 2026 Earnings EPS Surges Past Estimates Even as Copper Prices Weigh CIFR Q1 2026 Earnings Loss per Share Widens Misses Analyst Estimates HYPD Q1 2026 Earnings Significant EPS Miss Weighs on Investor Sentiment LILAK Q1 2026 Earnings Heavy EPS Miss Shakes Investor Confidence